Products for Research Use Only
RegisterLogin

Gal-ARV-771

CAT: 0804-HY-158331Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-158331Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Gal-ARV-771, PROTAC prodrug, is a gal modified ARV-771. Gal-ARV-771 can be activated in SA-β-Gal-expressed cancer senescent cells to release ARV-771. Gal-ARV-771 induces selective degradation of BRD4 protein by the ubiquitin-proteasome pathway in senescent cells. Gal-ARV-771 promotes apoptosis of senescent cancer cells[1].
CAS Number
3055593-64-8
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain; PROTACs
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gal-arv-771.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](C)C1=CC=C(C=C1)C2=C(N=CS2)C)[C@H]3N(C[C@@H](C3)OC(OCC4=CC=C(O[C@@H]([C@@H]5OC(C)=O)O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@@H]5OC(C)=O)C=C4)=O)C([C@H](C(C)(C)C)NC(COCCCOCCNC(C[C@@H]6N=C(C7=C(N8C(C)=NN=C68)SC(C)=C7C)C9=CC=C(C=C9)Cl)=O)=O)=O
Molecular Formula
C71H84ClN9O19S2
Molecular Weight
1467.06
References & Citations
[1]Chang M, et al. Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs. J Med Chem. 2024 May 9;67 (9) :7301-7311.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD4

Related Products

CatalogName
HY-100972-01ARV-771
HY-100972RARV-771 (Standard)
HY-156965-01BAY-771
HY-145264-01OARV-771
HY-158105-01ARV-393
HY-16954-01ARV-825
HY-W999697CRBN ligand-771
HY-153718KI-ARv-03
HY-147112MNP-GAL
HY-158460Alpha-Gal

Alternative Products

CatalogName
GTR19262283-01Gal-ARV-771
BA4656-50ARV-771
7256/5ARV 771

Popular Products